Ethris GmbH

2 clinical trials · Sponsor

Record	Firm	Date
Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge (NCT07059767)	Ethris GmbH	2025-06-24
A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants (NCT07055321)	Ethris GmbH	2023-11-29

Every clearance here is in the API, with alerts when new ones post.